Efficacy of Vaccine BNT162b2 (Pfizer-BioNTech) in Individuals with Waldenstrom's Macroglobulinemia and Follicular Lymphoma in Australia

por Beaton, Brendan, Sasson, Sarah C, Rankin, Katherine, Raedemaeker, Juliette, Wong, Alexander, Hastak, Priyanka, Warden, Andrew, Ospina Stella, Alberto, Aggarwal, Anupriya, Caterson, Ian D, Phetsouphanh, Chansavath, Turville, Stuart, Kelleher, Anthony D, Brilot, Fabienne, Trotman, Judith
Publicado 2021

COVID-19, impact on myeloma patients

por Dufour, Inès, Raedemaeker, Juliette, Andreozzi, Fabio, Verstraete, Géraldine, Bailly, Sarah, Delforge, Michel, Storms, Pauline, Jacquy, Caroline, Van de Velde, Ann, Mineur, Philippe, Lejeune, Marie, Bauwens, Deborah, Van Obbergh, Florence, Kentos, Alain, Nguyen, Jasmine, Fostier, Karel, De Weweire, Anne, Meuleman, Nathalie, Vekemans, Marie-Christiane
Publicado 2020

Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti‐spike neutralizing IgG to SARS‐CoV‐2 variants, but preserved antigen‐specific T cell responses...

por Beaton, Brendan, Sasson, Sarah C., Rankin, Katherine, Raedemaeker, Juliette, Wong, Alexander, Hastak, Priyanka, Phetsouphanh, Chansavath, Warden, Andrew, Klemm, Vera, Munier, C. Mee Ling, Hoppe, Alexandra Carey, Tea, Fiona, Pillay, Aleha, Stella, Alberto Ospina, Aggarwal, Anupriya, Lavee, Orly, Caterson, Ian D., Turville, Stuart, Kelleher, Anthony D., Brilot, Fabienne, Trotman, Judith
Publicado 2022